Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II trial of oral vinorelbine and cisplatin in unresectable locally advanced non-small cell lung cancer
2010-022927-31Phase 2Terminated
- Sponsor
- Fundación GECP
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing oral vinorelbine + cisplatin with etoposide + cisplatin (2 arms). Primary endpoint: Progression-free survival. Started Feb 2011; status: terminated.
02
Drugs
vinorelbinecisplatinetoposide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2010-022927-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022927-31.